China’s Industries to Watch in 2026
China’s 15th Five‑Year Plan signals a structural transformation rather than a short‑term recovery, reshaping the industrial landscape from 2026 onward. Businesses must reassess China strategies through the lens of competitiveness, security, and policy alignment.
EU-China Relations After the 2024 European Elections: A Timeline
Timeline tracking key developments affecting EU-China relations, including trade and business engagement, under the new European Parliament.
China’s FDI in 2025: A Year of Recalibration
China’s 2025 FDI performance reveals a clear divergence between capital inflows and market entry activity. While utilized FDI declined, services, manufacturing upgrading, and high‑tech industries continued to attract sustained foreign interest.
China and Canada Ease Tensions with Signing of Preliminary Trade Deal
China and Canada have reached a preliminary trade roadmap aimed at easing years of tensions. The China-Canada trade deal adjusts tariffs on EVs and agricultural goods while reopening dialogue on broader economic cooperation.
Trump 2.0 at One Year: What US–China Relations Could Look Like in 2026
After a year of upheaval, China and the US have settled into an uneasy but enduring truce. However, unresolved political, regulatory, and security tensions continue to shape the outlook for the year ahead.
China’s Economy in 2025: GDP Reaches 5.0% Growth Despite Challenges
China’s Economy in 2025 achieved its official growth target, underscoring macro‑level stability despite persistent demand‑side pressures. At the same time, sector‑level performance points to an economy still in the midst of structural adjustment.
Why China is Still the Top Manufacturing Destination in Asia
China retains its position as Asia’s top manufacturing destination in 2026, supported by world-class infrastructure, innovation capability, and policy reforms. While challenges exist, China’s scale and technological depth anchor its position.
Sports Medicine in China: Market Outlook, Regulatory Landscape, and Investment Insights
China’s sports medicine market is evolving into a key healthcare segment, supported by policy initiatives and demographic trends. Foreign investors have growing opportunities in devices, rehabilitation, and services.











